Staging lung cancer: total-body PET/CT or whole-body PET/CT?
Whole-Body imaging is sufficient to meet the clinical staging requirements for lung cancer. Although Total Body PET/CT detects more distal metastases in approximately 20% of stage IV lung cancer patients, it led to stage shift in only one patient and 0% change in the oncologic treatment.
Authors
- Xiaohui Chen (ORCID: https://orcid.org/0009-0005-8806-3851)
- Kemin Zhou (ORCID: https://orcid.org/0000-0002-4279-2515)
- Hubing Wu (ORCID: https://orcid.org/0000-0002-7546-5430)
- Wenlan Zhou (ORCID: https://orcid.org/0000-0001-9056-4835)
- Li Chen (ORCID: https://orcid.org/0000-0003-3758-0865)
- Penghui Sun (ORCID: https://orcid.org/0009-0007-9185-0906)
- Ying Tian (ORCID: https://orcid.org/0000-0002-6031-2335)
- Xiaoxiang Zhang (ORCID: https://orcid.org/0009-0005-9187-7151)
- Yashuang Zheng (ORCID: https://orcid.org/0000-0001-8326-2345)
- Jiahao Xie (ORCID: https://orcid.org/0009-0005-2575-2027)
Institutions
- Southern Medical University (CN)
Publication Details
- Journal
- EJNMMI Research
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1186/s13550-025-01317-4
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China